The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality

被引:13
作者
Zhou, Yanling [1 ,2 ]
Wang, Chengyu [1 ,2 ]
Lan, Xiaofeng [1 ,2 ]
Zheng, Wei [1 ,2 ]
Li, Hanqiu [1 ,2 ]
Chao, Ziyuan [1 ,2 ]
Wu, Kai [1 ,2 ,3 ]
McIntyre, Roger S. [4 ,5 ,6 ,7 ,8 ,9 ]
Ning, Yuping [1 ,2 ,10 ]
机构
[1] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Peoples R China
[2] Guangdong Engn Technol Res Ctr Translat Med Menta, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Mat Sci & Engn, Dept Biomed Engn, Guangzhou, Peoples R China
[4] Canadian Rapid Treatment Ctr Excellence, Mississauga, ON, Canada
[5] Univ Hlth Network, Poul Hansen Depress Ctr, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[8] Brain & Cognit Discovery Fdn, Toronto, ON, Canada
[9] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[10] Southern Med Univ, Sch Clin Med 1, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Cognition; Ketamine; Depression; Treatment resistance; Suicidality; DOUBLE-BLIND; NEUROCOGNITIVE PERFORMANCE; FUNCTIONAL OUTCOMES; ANTIDEPRESSANT; EFFICACY; ASSOCIATION; ESKETAMINE; IMPAIRMENT;
D O I
10.1016/j.jpsychires.2021.10.037
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Ketamine has rapid and robust antidepressant effects in depression, while its effects on cognitive measures are less clearly understood. This aim of the study herein is to determine whether ketamine has direct pro-cognitive effects in real-world treatment depression and/or suicidality. Methods: Subjects with unipolar (n = 84) and bipolar (n = 27) depression suffering treatment resistance or suicidality received six infusions of ketamine (0.5 mg/kg) during a 12-day period. Depression symptoms were assessed using the Montgomery-Asberg Depression Rating Scale at baseline, day 13 and day 26. Cognitive domains, including processing speed, working memory, visual learning and verbal learning were also measured using the MATRICS Consensus Cognitive Battery at the same time-points. Results: Significant improvement was observed in processing speed at day 13 (effect size [ES] = 0.501) and day 26 (ES = 0.654), and verbal learning at day 13 (ES = 0.362). Path analysis showed significant direct (beta = 2.444, P = 0.017) and indirect (beta = 1.220, P = 0.048) effect of ketamine on processing speed, indicating its improvement was partly independent of improvement in depressive symptoms. The direct effect (beta = 1.963, P = 0.052) of ketamine on verbal learning was not significant, whereas the indirect effect (beta = 1.386, P = 0.024) was significant, indicating treatment with ketamine indirectly improved verbal learning performance, via changes in depressive symptom. Conclusion: Six infusions of ketamine have a potential mood independent pro-cognitive effect on processing speed in adults with treatment depression and/or suicidality. The potential pro-cognitive effects of ketamine provide the basis for hypothesizing that other clinical outcomes (e.g., suicidality, functional impairment) reported with ketamine treatment may be in part mediated by improvement in cognition.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 53 条
  • [1] Cognitive Functioning in the First-Episode of Major Depressive Disorder: A Systematic Review and Meta-Analysis
    Ahern, Elayne
    Semkovska, Maria
    [J]. NEUROPSYCHOLOGY, 2017, 31 (01) : 52 - 72
  • [2] [Anonymous], 2016, INT J NEUROPSYCHOPH, DOI DOI 10.1093/ijnp/pyv082
  • [3] Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
    Basso, Laura
    Boenke, Luisa
    Aust, Sabine
    Gaertner, Matti
    Heuser-Collier, Isabella
    Otte, Christian
    Wingenfeld, Katja
    Bajbouj, Malek
    Grimm, Simone
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2020, 123 : 1 - 8
  • [4] Clinical, Functional, and Biological Correlates of Cognitive Dimensions in Major Depressive Disorder - Rationale, Design, and Characteristics of the Cognitive Function and Mood Study (CoFaM-Study)
    Baune, Bernhard T.
    Air, Tracy
    [J]. FRONTIERS IN PSYCHIATRY, 2016, 7
  • [5] Antidepressant effects of ketamine in depressed patients
    Berman, RM
    Cappiello, A
    Anand, A
    Oren, DA
    Heninger, GR
    Charney, DS
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (04) : 351 - 354
  • [6] Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
    Chen, Mu-Hong
    Li, Cheng-Ta
    Lin, Wei-Chen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Cheng, Chih-Ming
    Su, Tung-Ping
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 1 - 7
  • [7] Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies
    Crisanti, Camilla
    Enrico, Paolo
    Fiorentini, Alessio
    Delvecchio, Giuseppe
    Brambilla, Paolo
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 1109 - 1118
  • [8] Cognitive flexibility and performance in children and adolescents with threshold and sub-threshold bipolar disorder
    Dickstein, Daniel P.
    Axelson, David
    Weissman, Alexandra B.
    Yen, Shirley
    Hunt, Jeffrey I.
    Goldstein, Benjamin I.
    Goldstein, Tina R.
    Liao, Fangzi
    Gill, Mary Kay
    Hower, Heather
    Frazier, Thomas W.
    Diler, Rasim S.
    Youngstrom, Eric A.
    Fristad, Mary A.
    Arnold, L. Eugene
    Findling, Robert L.
    Horwitz, Sarah M.
    Kowatch, Robert A.
    Ryan, Neal D.
    Strober, Michael
    Birmaher, Boris
    Keller, Martin B.
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2016, 25 (06) : 625 - 638
  • [9] Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
    Duman, Ronald S.
    Aghajanian, George K.
    Sanacora, Gerard
    Krysta, John H.
    [J]. NATURE MEDICINE, 2016, 22 (03) : 238 - 249
  • [10] Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
    Enache, Daniela
    Pariante, Carmine M.
    Mondelli, Valeria
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 24 - 40